Related references
Note: Only part of the references are listed.Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies
Jennifer W. Wu et al.
DIABETES CARE (2016)
Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin
Javier Ampuero et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Reduced Risk of Lung Cancer With Metformin Therapy in Diabetic Patients: A Systematic Review and Meta-Analysis
Zhi-Jiang Zhang et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)
Anti-Diabetic Medications Do Not Influence Risk of Lung Cancer in Patients with Diabetes Mellitus: a Systematic Review and Meta-analysis
Shu-Ping Nie et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
Hannah R. Bridges et al.
BIOCHEMICAL JOURNAL (2014)
Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
Sara Gandini et al.
CANCER PREVENTION RESEARCH (2014)
Metformin and Cancer: Mounting Evidence Against an Association
Samy Suissa et al.
DIABETES CARE (2014)
Metformin Does Not Affect Cancer Risk: A Cohort Study in the UK Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
Konstantinos K. Tsilidis et al.
DIABETES CARE (2014)
Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
Zheng Wang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Association Between Intensification of Metformin Treatment With Insulin vs Sulfonylureas and Cardiovascular Events and All-Cause Mortality Among Patients With Diabetes
Christianne L. Roumie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Metformin-mode of action and clinical implications for diabetes and cancer
Ida Pernicova et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Effect of Metformin on Cancer Risk and Treatment Outcome of Prostate Cancer: A Meta-Analysis of Epidemiological Observational Studies
Hongliang Yu et al.
PLOS ONE (2014)
Anti-Diabetic Medications and Risk of Pancreatic Cancer in Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Tumor necrosis factor a inhibitor therapy and cancer risk in chronic immune-mediated diseases
Kevin Haynes et al.
ARTHRITIS AND RHEUMATISM (2013)
Association of metformin use with cancer incidence and mortality: A meta-analysis
Pengpeng Zhang et al.
CANCER EPIDEMIOLOGY (2013)
Validation of VA Administrative Data Algorithms for Identifying Cardiovascular Disease Hospitalization
Kurt Niesner et al.
EPIDEMIOLOGY (2013)
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis
Hui Zhang et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Use of Insulin and Insulin Analogs and Risk of Cancer - Systematic Review and Meta-Analysis of Observational Studies
Oystein Karlstad et al.
CURRENT DRUG SAFETY (2013)
Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus A Cohort Study
Christianne L. Roumie et al.
ANNALS OF INTERNAL MEDICINE (2012)
Metformin and breast cancer risk: a meta-analysis and critical literature review
Nananda F. Col et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Metformin and the Risk of Cancer Time-related biases in observational studies
Samy Suissa et al.
DIABETES CARE (2012)
Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Zhi-Jiang Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Comparative effectiveness of incident oral antidiabetic drugs on kidney function
Adriana M. Hung et al.
KIDNEY INTERNATIONAL (2012)
Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
Davide Soranna et al.
ONCOLOGIST (2012)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto et al.
PLOS ONE (2012)
Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes A meta-analysis
Zhi-Jiang Zhang et al.
DIABETES CARE (2011)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target
J. G. Boyle et al.
DIABETIC MEDICINE (2010)
Metformin: Taking away the candy for cancer?
Mathilde Jalving et al.
EUROPEAN JOURNAL OF CANCER (2010)
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
Issam Ben Sahra et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Statins and cancer: A systematic review and meta-analysis
Jaana Kuoppala et al.
EUROPEAN JOURNAL OF CANCER (2008)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information
S Schneeweiss et al.
EPIDEMIOLOGY (2005)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Share Paper
